Summary

The DNA synthesis market was valued at $5.7 billion in 2025 and is estimated to reach $30.4 billion by 2035, exhibiting a CAGR of 18.2% from 2026 to 2035. DNA synthesis refers to the artificial creation of DNA molecules through chemical or enzymatic methods, enabling researchers to design, assemble, and produce customized DNA sequences for a wide range of applications. It plays a critical role in modern biotechnology, molecular biology, synthetic biology, drug discovery, and genetic engineering. DNA synthesis technologies include oligonucleotide synthesis and gene synthesis, which allow the production of short DNA fragments as well as full-length genes with high precision and scalability. These synthesized DNA sequences are widely used in research, diagnostics, therapeutics development, vaccine design, and agricultural biotechnology, making them a foundational tool in life sciences innovation.
The DNA synthesis market has witnessed strong growth, primarily driven by the rise in demand for advanced genomic research and surge in applications in personalized medicine and precision therapeutics. Increase in investments in biotechnology and pharmaceutical R&D have significantly boosted the adoption of synthetic DNA for drug discovery, target validation, and biomarker identification. In addition, the rapid growth of synthetic biology and genetic engineering applications, such as CRISPR-based gene editing, has further accelerated market expansion. The surge in prevalence of chronic and infectious diseases has also intensified the need for rapid diagnostic development and vaccine research, thereby increasing reliance on DNA synthesis technologies across healthcare and research institutions.
However, the market faces certain restraints, including the high cost associated with high-fidelity DNA synthesis and sequencing error correction, which limits accessibility for smaller research laboratories and startups. In addition, technical limitations in synthesizing longer and highly complex DNA sequences with absolute accuracy continue to pose challenges. Regulatory concerns related to biosecurity and the ethical implications of synthetic gene creation also restrict unrestricted market expansion in several regions.
Despite these challenges, the advancements in enzymatic DNA synthesis technologies, which offer higher speed, scalability, and reduced error rates compared to traditional chemical methods, offer significant opportunities for market expansion. The surge in demand for synthetic biology-based solutions in industrial biotechnology, agriculture, and healthcare is expected to further expand application areas. Emerging economies in Asia-Pacific, particularly India and China, are becoming key growth hubs due to increase in investments in genomics infrastructure, surge in number of biotech startups, and supportive government initiatives promoting life sciences research.
The DNA synthesis market is segmented into product & services, type, application, end user, and region. On the basis of product & services, it is bifurcated into product and services. The product segment is further divided into instruments and reagent & consumables. On the basis of type, the market is segregated into oligonucleotide synthesis and gene synthesis. On the basis of application, the market is categorized into diagnostics, therapeutics, and research & development. On the basis of end user, the market is fragmented into pharmaceutical & biotechnology companies, diagnostic companies, academic & research institutes, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report are Danaher Corporation, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Twist Bioscience, GenScript Biotech Corporation, Merck KGaA, Bioneer Corporation, Telesis Bio, Azenta Inc., and Ajinomoto Bio-Pharma.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dna synthesis market analysis from 2025 to 2035 to identify the prevailing dna synthesis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the dna synthesis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global dna synthesis market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.


Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
Additional company profiles with specific to client's interest
Expanded list for Company Profiles
Historic market data

Key Market Segments By Type Oligonucleotide Synthesis
Gene Synthesis
By Application Diagnostics
Therapeutics
Research and Development
By Product and Service Product Type
Instruments
Reagents and Consumables
Services
By End User Pharmaceutical and Biotechnology Companies
Diagnostic Companies
Academic and Research Institutes
Others
By Region North America U.S.
Canada
Mexico
Europe Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Eurofins Scientific SE
Twist Bioscience
GenScript Biotech Corporation
Bioneer Corporation
Telesis Bio
Ajinomoto Bio-Pharma
Thermo Fisher Scientific Inc.
Merck KGaA
Azenta Inc.
Danaher Corporation

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. High intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rising Demand for Genomics and Precision Medicine
3.4.1.2. Growth in Synthetic Biology and Biopharmaceutical Innovation
3.4.1.3. Technological Advancements in Automation and High-Throughput Synthesis
3.4.2. Restraints
3.4.2.1. High Cost and Technical Complexity of Long-Sequence DNA Synthesis
3.4.2.2. Ethical, Regulatory, and Biosecurity Concerns
3.4.3. Opportunities
3.4.3.1. Expansion of Gene and Cell Therapy Applications

CHAPTER 4: DNA SYNTHESIS MARKET, BY PRODUCT AND SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Product
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Product DNA Synthesis Market by Type
4.2.4.1. Instruments Market size and forecast, by region
4.2.4.2. Reagents and Consumables Market size and forecast, by region
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country

CHAPTER 5: DNA SYNTHESIS MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Oligonucleotide Synthesis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Gene Synthesis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country

CHAPTER 6: DNA SYNTHESIS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostics
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Therapeutics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Research and Development
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country

CHAPTER 7: DNA SYNTHESIS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceutical and Biotechnology Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Diagnostic Companies
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Research Institutes
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country

CHAPTER 8: DNA SYNTHESIS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Product and Service
8.2.2.1. North America Product DNA Synthesis Market by Type
8.2.3. Market size and forecast, by Type
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Product and Service
8.2.6.1.2. Market size and forecast, by Type
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Product and Service
8.2.6.2.2. Market size and forecast, by Type
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Product and Service
8.2.6.3.2. Market size and forecast, by Type
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Product and Service
8.3.2.1. Europe Product DNA Synthesis Market by Type
8.3.3. Market size and forecast, by Type
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Product and Service
8.3.6.1.2. Market size and forecast, by Type
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Product and Service
8.3.6.2.2. Market size and forecast, by Type
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Product and Service
8.3.6.3.2. Market size and forecast, by Type
8.3.6.3.3. Market size habits and forecast, by Application
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Product and Service
8.3.6.4.2. Market size and forecast, by Type
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Product and Service
8.3.6.5.2. Market size and forecast, by Type
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Product and Service
8.3.6.6.2. Market size and forecast, by Type
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Product and Service
8.4.2.1. Asia-Pacific Product DNA Synthesis Market by Type
8.4.3. Market size and forecast, by Type
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Product and Service
8.4.6.1.2. Market size and forecast, by Type
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Product and Service
8.4.6.2.2. Market size and forecast, by Type
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Product and Service
8.4.6.3.2. Market size and forecast, by Type
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Product and Service
8.4.6.4.2. Market size and forecast, by Type
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Product and Service
8.4.6.5.2. Market size and forecast, by Type
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Product and Service
8.4.6.6.2. Market size and forecast, by Type
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Product and Service
8.5.2.1. LAMEA Product DNA Synthesis Market by Type
8.5.3. Market size and forecast, by Type
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Product and Service
8.5.6.1.2. Market size and forecast, by Type
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Product and Service
8.5.6.2.2. Market size and forecast, by Type
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Product and Service
8.5.6.3.2. Market size and forecast, by Type
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Product and Service
8.5.6.4.2. Market size and forecast, by Type
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2025

CHAPTER 10: COMPANY PROFILES
10.1. Bioneer Corporation
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. Danaher Corporation
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Eurofins Scientific SE
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.4. Thermo Fisher Scientific Inc.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. Twist Bioscience
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. GenScript Biotech Corporation
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. Telesis Bio
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. Azenta Inc.
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.9. Ajinomoto Bio-Pharma
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.10. Merck KGaA
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance